Please login to the form below

Not currently logged in
Email:
Password:

Stem cell

This page shows the latest Stem cell news and features for those working in and with pharma, biotech and healthcare.

Plasticell and London’s gene therapy pioneers to tackle manufacturing conundrum

Plasticell and London’s gene therapy pioneers to tackle manufacturing conundrum

Plasticell is based at the nearby biotech hub just outside London in Stevenage, and is working on stem cell technologies and therapies. ... We have previously used CombiCult to develop cell culture media that expand hematopoietic stem cells and,

Latest news

More from news
Approximately 7 fully matching, plus 191 partially matching documents found.

Latest Intelligence

  • Reaching the new influencers Reaching the new influencers

    Right now, we’re living through healthcare’s age of accelerations - as evidenced by advances in everything from biotechnology and stem cell research to machine learning and the advent (and approvals)

  • Can value-based healthcare take off and reach for the skies? Can value-based healthcare take off and reach for the skies?

    CAR-T cell therapy for children with B-cell ALL. ... way under the cost-effective price and significantly lower than the current standard of allogenic stem cell transplant that costs $500, 000-800, 000 in the first year with follow-up

  • Deal Watch January 2018

    Takeda moves in neurodegenerative diseases and stem cell therapy. Meanwhile Takeda, ranked 4. ... A few days later Takeda announced it was paying $628m (82% share price premium) to buy Belgian company TiGenix NV and its lead asset Cx601 (darvadstrocel),

  • Pharma deals continue to slide Pharma deals continue to slide

    425 (upfront 80). Calimmune (US). CSL (AU). Company acquisition. Preclinical haematopoietic stem cell therapy for sickle cell disease.

  • Can UK pharma rise to the post-Brexit challenge? Can UK pharma rise to the post-Brexit challenge?

    to deliver a medicine, and it is much easier to secure funding for stem cell research for developing advanced therapies in the UK compared to the US.

More from intelligence
Approximately 0 fully matching, plus 26 partially matching documents found.

Latest appointments

  • Weekly industry appointments Weekly industry appointments

    There, he is medicines development leader for adenosine deaminase deficiency (ADA-SCID) gene therapy Strimvelis – the first alternative medicine to stem cell transplant for the disease that’s bagged a regulatory ... be a global leader in the

  • Porterhouse Medical promotes Emma Conran Porterhouse Medical promotes Emma Conran

    Conran has served in medical writing positions at Porterhouse Medical since 2014 and prior to that she was a translational stem cell biology lecturer at King’s College London.

  • apceth Biopharma appoints Dusan Kosijer as CFO apceth Biopharma appoints Dusan Kosijer as CFO

    apceth Biopharma appoints Dusan Kosijer as CFO. He joins the cell therapy company from Accovion GmbH. ... Moreover, Dusan’s experience will strongly promote our dynamic innovative strategy behind apceth’s unique proprietary pipeline of genetically

  • Dr Jay Stout moves from Merck to SanBio Dr Jay Stout moves from Merck to SanBio

    In this role, he is responsible for all production-related operations, including clinical cell preparation, final quality assurance and process development. ... He is perhaps the individual with the greatest experience in the world in manufacturing

  • Plasticell names Aaron Chuang as chief scientific officer Plasticell names Aaron Chuang as chief scientific officer

    Chuang initiated the first stem cell drug discovery programme at GSK in 2004 and was central in the firm's stem cell R&D. ... He was also prominent in establishing GSK's alliance with the Harvard Stem Cell Institute in 2008 and coordinated all

More from appointments
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest from PMHub

  • Training the next generation of biotech leaders

    Training the next generation of biotech leaders. Cell and gene therapy is no longer science fiction. ... Brexit and the skills shortage. Dr Ivan Wall is an expert in all things stem cell.

  • Biotech: it's a people business

    From Johnson &Johnson’ s immunology treatments to Pfizer’ s work on a stem cell-based remedy for age-related macular degeneration, pharma companies are quickly realising biotechnology is the future of

  • Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies

    stem cell therapy and to learn his perspective on navigating the challenges that come with developing products in this complex market. ... Image: Olav Hallebo, CEO, ReNeuron. The global stem cell market is predicted to reach  $270.5bn by 2025.

  • How do you define a biotech company?

    ReNeuron, a leading, clinical-stage stem cell business.

  • Healthcare in the Digital Age

    Exciting developments in immunotherapy and oncology, and huge strides in gene and stem-cell therapy are matched by powerhouse collaborations between academia and industry that point to a golden age for

More from PMHub
Approximately 2 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics